Tuesday
09.17.2019
7:29 PM
Login form
Search
Calendar
Entries archive

My site

Main » 2019 » March » 27

Britain’s largest premium vaping brand, IVG Premium E-Liquids, and Australia’s premier solutions specialist, Kollaras & Co, will now provide Australian vapers with access to IVG’s award winning flavours.

 

PRESTON, England-Monday 25 March 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- IVG Premium E-Liquids, the UK’s market-leading brand, has announced a strategic partnership with globally renowned Kollaras & Co – A 3rd generation, family owned and operated business. Kollaras & Co specialises in supporting independent retailers across multiple channels in Australia.

Kollaras & Co have landed the master distribution rights for IVG products within Australia, which will allow vapers from down under to join vapers from over 60 countries and 6 continents that vape premium British flavours from IVG.

John Kollaras, Managing Director of Kollaras & Co, commented that the alliance was an important step for th ... Read more »

Views: 26 | Added by: africa-live | Date: 03.27.2019 | Comments (0)

DUBAI, United Arab Emirates-Tuesday 26 March 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- International General Insurance Holdings Limited today reported earnings for the 2018 financial year.

The year 2018 saw a strong recovery for IGI following the most expensive year for catastrophe losses on record in 2017. The Group has a clear and focused vision of growth in new and existing markets, putting IGI back in track for another robust performance for the 2018 financial year.

Gross written premium (GWP) rose by 9.5% to US $301.56 million in 2018, compared to US $275.3 million the year before. The Group announced a 237% increase in net profit to US$ 26.47 million from US $7.86 million as at 31 December 2017. The combined operating ratio was 88.97%, considerably down from last year’s figure of 103.08%.

The total assets of the company increased by 2.09% to US $907.35 million in 2018 from US$ 888.79 million in 2017.

Mr. Wasef Jabsheh, Vice Chairman an ... Read more »

Views: 25 | Added by: africa-live | Date: 03.27.2019 | Comments (0)

OSAKA, Japan -Tuesday 26 March 2019 [ AETOS Wire ]

Impact on patient quality of life quantified including long-term renal and cardiovascular complications
Final outcomes of 6 year study into continuous use of rhPTH(1-84) shows improvements in key measurements of mineral homeostasis
 

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) this week shared new data revealing the burden of chronic hypoparathyroidism on patients and caregivers, as well as potential long-term risks of renal and cardiovascular complications that patients treated with conventional therapy may experience. Six-year results from the open-label long-term safety and efficacy RACE study were also announced. Data was presented at the Endocrine Society’s 2019 Annual Meeting (ENDO) from 23–26 March in New Orleans, Louisiana, USA.

“Results from the Burden of Illness Global Survey in 13 countries reveal the extent o ... Read more »

Views: 26 | Added by: africa-live | Date: 03.27.2019 | Comments (0)

In a historic deal with Shanghai Waigaoqiao Shipbuilding Co., Ltd. (SWS), ABB will supply a comprehensive power and propulsion package for China’s first domestically built cruise ship 

SHANGHAI-Tuesday 26 March 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- ABB has been awarded a contract to supply an integrated package, including two Azipod® steerable propulsion systems, for the construction of China’s first ever home-grown cruise ship. ABB’s deep domain knowledge in cruise technology coupled with its local expertise makes it the perfect partner to support this significant milestone in the evolution of China’s shipbuilding industry.

The 323-meter vessel, due for delivery in 2023, can accommodate 5,000 passengers and is designed to suit the tastes of Chinese cruise travelers whose numbers are expected to rise to 8-10 million annually by 2025, according to industry body Cruise Lines International Association (CLIA).

“With ... Read more »

Views: 23 | Added by: africa-live | Date: 03.27.2019 | Comments (0)

NEW YORK -Tuesday 26 March 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- Brookstone Partners, the majority shareholder of Platinum Power, rejects the accuracy of Mr. Omar Belmamoun's statements in a press release issued on March 21, 2019.

According to Brookstone Partners, “the Court procedure to which Mr. Belmamoun refers to is an alert procedure introduced by Platinum Power's Statutory Auditor due to the company's serious financial difficulties which were the direct consequence of Mr. Belmamoun’s disastrous management.’ Brookstone Partners has not initiated any 'judicial restructuring' and therefore, dismissal from any such action is irrelevant."

As a majority investor, Brookstone Partners welcomes the court’s decision regarding the continuation of Platinum Power’s business and reiterates its willingness to work with all shareholders, including minority shareholders, who have consistently demonstrated a strong d ... Read more »

Views: 27 | Added by: africa-live | Date: 03.27.2019 | Comments (0)

SUMMIT, N.J.-Wednesday 27 March 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis (RMS). Ozanimod is an oral, sphingosine 1-phosphate (S1P) receptor modulator, which binds with high affinity selectively to S1P subtypes 1 (S1P1) and 5 (S1P5).

The pivotal efficacy and safety data provided in the application result from the SUNBEAM™ and RADIANCE™ Part B phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled trials.

“New oral treatment options with differentiated profiles like ozanimod are needed to help address an unmet need for people with relapsing forms of MS,” said Jay Backstrom, M.D., Chief Medical Officer for Celgene. “With concurrent applications in the U.S. and EU, we look forward ... Read more »

Views: 26 | Added by: africa-live | Date: 03.27.2019 | Comments (0)

Trueman Man Clinic Achieves 10000 Surgery Milestone with Its SWITCH Operation-Tuesday 26 March 2019 [ AETOS Wire ]

 

(BUSINESS WIRE)-- Trueman Man Clinic Network announced that the 10,000th surgery utilizing its SWITCH Premature Ejaculation Surgery (Nerve Conservation), has been successfully completed. ... Read more »

Views: 71 | Added by: africanewsline | Date: 03.27.2019 | Comments (0)

PARIS-Tuesday 26 March 2019 [ AETOS Wire ]

 

(BUSINESS WIRE)-- Bertin Technologies, a subsidiary of CNIM Group, has received a contract from  ... Read more »

Views: 39 | Added by: africanewsline | Date: 03.27.2019 | Comments (0)

Panasonic’s next-generation HD-PLC® technology for IoT-related services was adopted as the IEEE 1901a standard. It allows scalable communications with speed or distance depending on IoT applications.


OSAKA, Japan -Tuesday 26 March 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- On March 25, 2019, Panasonic Corporation announced that the IEEE Standards Association has approved the company’s next-generation broadband over powerline (BPL) communication technology for Internet of Things (IoT) as the IEEE 1901a Standard on March 21, 2019 at the Standards Board meeting in Munich, Germany. The company proposed the technology to the IEEE Standardization 1901a Working Group*2 in June 2018. This standard flexibly meets various demands for IoT-related services.

IEEE 1901a, BPL communication standard for IoT enables to control frequency bands according to usage. It allows scalable communications with features to extend communication distances and to select s ... Read more »

Views: 27 | Added by: africanewsline | Date: 03.27.2019 | Comments (0)